MX2015012540A - Ratón de cadena ligera común. - Google Patents
Ratón de cadena ligera común.Info
- Publication number
- MX2015012540A MX2015012540A MX2015012540A MX2015012540A MX2015012540A MX 2015012540 A MX2015012540 A MX 2015012540A MX 2015012540 A MX2015012540 A MX 2015012540A MX 2015012540 A MX2015012540 A MX 2015012540A MX 2015012540 A MX2015012540 A MX 2015012540A
- Authority
- MX
- Mexico
- Prior art keywords
- light chain
- bispecific antibodies
- chain variable
- antigens
- mice
- Prior art date
Links
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 abstract 2
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 abstract 2
- 241000699666 Mus <mouse, genus> Species 0.000 abstract 2
- 241000699670 Mus sp. Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 210000004602 germ cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/01—Animal expressing industrially exogenous proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/515—Complete light chain, i.e. VL + CL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biodiversity & Conservation Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Husbandry (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Image Processing (AREA)
Abstract
Se proporciona un ratón genéticamente modificado, en donde el ratón expresa un repertorio de cadena ligera de inmunoglobulina caracterizado por un número limitado de dominios variables de cadena ligera. Se proporcionan ratones que expresan solamente uno o unos cuantos dominios variables de cadena ligera de inmunoglobulina a partir de un repertorio limitado en su línea germinal. Se proporcionan métodos para la elaboración de anticuerpos biespecíficos que tienen cadenas ligeras universales utilizando ratones como se describen en la presente, incluyendo las regiones variables de cadena ligera humanas. Se proporcionan métodos para la elaboración de regiones variables humanas adecuadas para utilizarse en las proteínas de enlace multiespecíficas, por ejemplo, anticuerpos biespecíficos, y células huésped. Se proporcionan anticuerpos biespecíficos capaces de enlazarse con primero y el segundo antígenos, en donde los primero y segundo antígenos son epítopos separados de una sola proteína, o epítopos separados de dos proteínas diferentes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/798,310 US20130185821A1 (en) | 2010-02-08 | 2013-03-13 | Common Light Chain Mouse |
PCT/US2014/025982 WO2014160179A1 (en) | 2013-03-13 | 2014-03-13 | Common light chain mouse |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2015012540A true MX2015012540A (es) | 2016-04-19 |
Family
ID=50555217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015012540A MX2015012540A (es) | 2013-03-13 | 2014-03-13 | Ratón de cadena ligera común. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2970437A1 (es) |
JP (1) | JP2016519568A (es) |
KR (1) | KR20150126863A (es) |
CN (1) | CN105189545A (es) |
AU (1) | AU2014244079A1 (es) |
CA (1) | CA2903696A1 (es) |
HK (1) | HK1218550A1 (es) |
IL (1) | IL240562A0 (es) |
MX (1) | MX2015012540A (es) |
NL (4) | NL2012424C2 (es) |
RU (1) | RU2015143108A (es) |
SG (1) | SG11201506294TA (es) |
WO (1) | WO2014160179A1 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS59001B1 (sr) | 2010-02-08 | 2019-08-30 | Regeneron Pharma | Miš sa zajedničkim lakim lancem |
US9796788B2 (en) | 2010-02-08 | 2017-10-24 | Regeneron Pharmaceuticals, Inc. | Mice expressing a limited immunoglobulin light chain repertoire |
US20130045492A1 (en) | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
SG10201606158TA (en) | 2011-08-05 | 2016-09-29 | Regeneron Pharma | Humanized universal light chain mice |
KR20210088756A (ko) | 2014-03-21 | 2021-07-14 | 리제너론 파마슈티칼스 인코포레이티드 | 단일 도메인 결합 단백질을 생산하는 비-인간 동물 |
AU2016232715A1 (en) | 2015-03-19 | 2017-09-28 | Regeneron Pharmaceuticals, Inc. | Non-human animals that select for light chain variable regions that bind antigen |
WO2017123804A1 (en) | 2016-01-13 | 2017-07-20 | Regeneron Pharmaceuticals, Inc. | Rodents having an engineered heavy chain diversity region |
GB201710984D0 (en) | 2017-07-07 | 2017-08-23 | Kymab Ltd | Cells, vertebrates, populations & methods |
AU2019287727B2 (en) | 2018-06-14 | 2022-12-01 | Regeneron Pharmaceuticals, Inc. | Non-human animals capable of DH-DH rearrangement in the immunoglobulin heavy chain coding sequences |
KR20210129083A (ko) | 2019-02-22 | 2021-10-27 | 리제너론 파마슈티칼스 인코포레이티드 | 유전적으로 변형된 나트륨 채널을 갖는 설치류 및 이의 사용 방법 |
BR112021023683A2 (pt) * | 2019-06-05 | 2022-02-01 | Regeneron Pharma | Roedor e camundongo geneticamente modificado, embrião de roedor, célula b do roedor ou camundongo geneticamente modificado, hibridoma, população de células b, célula-tronco embrionária, célula de mamífero, métodos de produção de um anticorpo, de uma cadeia pesada, de um domínio variável, de uma coleção de domínios variáveis, de uma cadeia leve, de uma sequência nucleotídica, de um roedor geneticamente modificado e de células es, de geração de um domínio variável e in vitro para gerar uma célula recombinante de roedor, e, vetor de direcionamento |
KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
AU2021342159A1 (en) | 2020-09-11 | 2023-03-02 | Regeneron Pharmaceuticals, Inc. | Identification and production of antigen-specific antibodies |
IL303626A (en) | 2020-12-16 | 2023-08-01 | Regeneron Pharma | Mice expressing human FC alpha receptors |
MX2023007401A (es) | 2020-12-23 | 2023-07-06 | Regeneron Pharma | Acidos nucleicos que codifican anticuerpos modificados por anclaje y usos de los mismos. |
EP4267608A1 (en) | 2020-12-23 | 2023-11-01 | Regeneron Pharmaceuticals, Inc. | Methods for obtaining antibodies that bind transmembrane proteins and cells that produce the same |
GB202107372D0 (en) | 2021-05-24 | 2021-07-07 | Petmedix Ltd | Animal models and therapeutics molecules |
GB202209247D0 (en) | 2022-06-23 | 2022-08-10 | Petmedix Ltd | Animal models and therapeutic molecules |
GB202216503D0 (en) | 2022-11-05 | 2022-12-21 | Quadrucept Bio Ltd | Non-human vertebrates & cells |
GB202217978D0 (en) | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6774279B2 (en) | 1997-05-30 | 2004-08-10 | Carnegie Institution Of Washington | Use of FLP recombinase in mice |
US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
CA2965865C (en) * | 2002-07-18 | 2021-10-19 | Merus N.V. | Recombinant production of mixtures of antibodies |
US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
WO2005007696A2 (en) * | 2003-07-15 | 2005-01-27 | Therapeutic Human Polyclonals, Inc. | Humanized immunoglobulin loci |
US7294754B2 (en) | 2004-10-19 | 2007-11-13 | Regeneron Pharmaceuticals, Inc. | Method for generating an animal homozygous for a genetic modification |
SI2041177T1 (sl) | 2006-06-02 | 2012-03-30 | Regeneron Pharma | Visoko afinitetna protitelesa za humani IL receptor |
TWI507525B (zh) | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
RS59001B1 (sr) * | 2010-02-08 | 2019-08-30 | Regeneron Pharma | Miš sa zajedničkim lakim lancem |
US20120021409A1 (en) * | 2010-02-08 | 2012-01-26 | Regeneron Pharmaceuticals, Inc. | Common Light Chain Mouse |
US20130045492A1 (en) * | 2010-02-08 | 2013-02-21 | Regeneron Pharmaceuticals, Inc. | Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain |
CA2865029A1 (en) * | 2012-03-06 | 2013-09-12 | Regeneron Pharmaceuticals, Inc. | Common light chain mouse |
JP2015525071A (ja) * | 2012-06-05 | 2015-09-03 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. | 共通の軽鎖を用いて完全ヒト型二重特異性抗体を作製するための方法 |
-
2014
- 2014-03-13 EP EP14722432.3A patent/EP2970437A1/en not_active Withdrawn
- 2014-03-13 AU AU2014244079A patent/AU2014244079A1/en not_active Abandoned
- 2014-03-13 RU RU2015143108A patent/RU2015143108A/ru not_active Application Discontinuation
- 2014-03-13 MX MX2015012540A patent/MX2015012540A/es unknown
- 2014-03-13 NL NL2012424A patent/NL2012424C2/en active
- 2014-03-13 SG SG11201506294TA patent/SG11201506294TA/en unknown
- 2014-03-13 WO PCT/US2014/025982 patent/WO2014160179A1/en active Application Filing
- 2014-03-13 CA CA2903696A patent/CA2903696A1/en not_active Abandoned
- 2014-03-13 CN CN201480013861.1A patent/CN105189545A/zh active Pending
- 2014-03-13 KR KR1020157025655A patent/KR20150126863A/ko not_active Application Discontinuation
- 2014-03-13 JP JP2016502014A patent/JP2016519568A/ja active Pending
- 2014-11-21 NL NL2013851A patent/NL2013851C2/en active
-
2015
- 2015-05-07 NL NL2014775A patent/NL2014775B1/en active
- 2015-08-13 IL IL240562A patent/IL240562A0/en unknown
- 2015-10-12 NL NL2015603A patent/NL2015603B1/en active
-
2016
- 2016-06-06 HK HK16106452.0A patent/HK1218550A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
NL2013851A (en) | 2015-01-12 |
CA2903696A1 (en) | 2014-10-02 |
IL240562A0 (en) | 2015-09-24 |
NL2012424A (en) | 2014-09-16 |
KR20150126863A (ko) | 2015-11-13 |
AU2014244079A1 (en) | 2015-09-24 |
NL2013851C2 (en) | 2015-06-08 |
CN105189545A (zh) | 2015-12-23 |
HK1218550A1 (zh) | 2017-02-24 |
JP2016519568A (ja) | 2016-07-07 |
NL2012424C2 (en) | 2014-12-08 |
NL2015603A (en) | 2016-03-16 |
WO2014160179A4 (en) | 2014-11-20 |
RU2015143108A (ru) | 2017-04-20 |
NL2014775B1 (en) | 2016-03-16 |
WO2014160179A1 (en) | 2014-10-02 |
NL2014775A (en) | 2015-06-09 |
EP2970437A1 (en) | 2016-01-20 |
NL2015603B1 (en) | 2016-09-23 |
SG11201506294TA (en) | 2015-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015012540A (es) | Ratón de cadena ligera común. | |
MX353278B (es) | Raton con cadena ligera comun. | |
MX2015012539A (es) | Ratones que expresan un repertorio limitado de cadena ligera de inmunoglobulina. | |
CY1122036T1 (el) | Μη ανθρωπινα ζωα που εκφραζουν αντισωματα τα οποια εχουν μια κοινη ελαφρια αλυσιδα | |
MX2022011659A (es) | Proteinas de union a antigeno que se unen a pd-l1. | |
PH12018502478A1 (en) | Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen | |
NZ732628A (en) | Bispecific tetravalent antibodies with binding specificity for first and second egfr family members and methods of making and using thereof | |
EA201791666A1 (ru) | Антитела к cd3, антитела к cd123 и биспецифические антитела, которые специфически связываются с cd3 и/или cd123 | |
EA201791139A1 (ru) | Гетеродимерные антитела, которые связывают cd3 и опухолевые антигены | |
EA201792467A1 (ru) | Гетеродимерные антитела, которые связывают cd3 и опухолевые антигены | |
EA201791961A1 (ru) | Антитела, специфичные к cd47 и pd-l1 | |
EA201890285A1 (ru) | Антитела против pd-1, активируемые антитела против pd-1 и способы их применения | |
WO2014012085A3 (en) | Bispecific asymmetric heterodimers comprising anti-cd3 constructs | |
EA201692504A1 (ru) | Триспецифичные связывающие молекулы и способы их применения | |
EP4223874A3 (en) | Human anti-il-33 neutralizing monoclonal antibody | |
BR112016014022A2 (pt) | anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit | |
MX2021001074A (es) | Ratones de cadena ligera universal humanizados. | |
DOP2013000129A (es) | PROTEÍNAS DE UNIÓN AL TNF-a. | |
NZ628528A (en) | Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof | |
MX355732B (es) | Anticuerpos con cadena ligera modificada con histidina por ingenieria genetica y animales no humanos geneticamente modificados para generarlos. | |
NZ627977A (en) | Humanized rodents that express heavy chains containing vl domains | |
EA201792193A1 (ru) | Конструкции биспецифического антитела для cdh3 и cd3 | |
MY191512A (en) | Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same | |
EA201990894A1 (ru) | Анти-pd-1/анти-her2 гетеродимерное биспецифическое антитело со структурой природного антитела и способ его получения | |
MX2016012273A (es) | Proteinas de union al antigeno vl que presentan diferentes caracteristicas de union. |